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 ABSTRACT 25 
The reverse zoonotic events that introduced the 2009 pandemic influenza virus into pigs have 26 
drastically increased the diversity of swine influenza viruses in Europe. The pandemic potential of 27 
these novel reassortments is still unclear, necessitating enhanced surveillance of European pigs with 28 
additional focus on risk assessment of these new viruses. In this study, four European swine influenza 29 
viruses were assessed for their zoonotic potential. Two of the four viruses were enzootic viruses of 30 
subtype H1N2 (with avian-like H1) and H3N2 and two were new reassortants, one with avian-like H1 31 
and human-like N2 and one with 2009 pandemic H1 and swine-like N2. All viruses replicated to high 32 
titers in nasal wash- and nasal turbinate samples from inoculated ferrets and transmitted efficiently by 33 
direct contact. Only the H3N2 virus transmitted to naïve ferrets via the airborne route. Growth kinetics 34 
using a differentiated human bronchial epithelial cell line showed that all four viruses were able to 35 
replicate to high titers. Further, the viruses revealed preferential binding to the α2,6-silalylated glycans 36 
and investigation of the antiviral susceptibility of the viruses revealed that all were sensitive to 37 
neuraminidase inhibitors. These findings suggest that these viruses have the potential to infect humans 38 
and further underline the need for continued surveillance as well as biological characterization of new 39 
influenza A viruses.  40 
 41 
 42 
 43 
 44 
 45 
  46 
INTRODUCTION 47 
Influenza A virus (IAV) causes disease in humans, birds and some domestic animals, including swine. 48 
Swine influenza viruses (SIV) are enzootic in pigs worldwide and infection with the virus causes 49 
substantial economic loss for farmers due to secondary infections and reduced weight gain in affected 50 
pigs. Further, the presence of IAV in swine also pose a potential health risk to humans due to 51 
development of new reassortant viruses with zoonotic potential as recently seen with the 2009 H1N1 52 
pandemic virus (H1N1pdm09) (Smith et al., 2009).  53 
Within the last few years, several new reassortant SIV have been detected throughout Europe, Asia and 54 
the US (Breum et al., 2013; Moreno et al., 2011; Pascua et al., 2013; Starick et al., 2011, 2012; 55 
Tremblay et al., 2011), with many carrying segments from enzootic SIVs and the H1N1pdm09 virus.  56 
In Denmark, at least four SIV subtypes are enzootic in pigs, the avian-like H1N1 (H1N1), being the 57 
result of a transmission event from birds to swine (Abusugra et al., 1987; Schultz et al., 1991), the 58 
European reassortant human-like H3N2 (H3N2), with surface glycoproteins of human origin and a 59 
backbone derived from the avian-like H1N1 (Castrucci et al., 1993). The third subtype is an avian-like 60 
H1N2 (H1N2) containing seven segments originating from H1N1 and N2 from H3N2 (Trebbien et al., 61 
2013). Finally, in 2010 a reverse zoonotic event led to the introduction of the H1N1pdm09 into Danish 62 
pigs. The virus spread and rapidly achieved a prevalence of 15-20% of SIVs isolated in the country 63 
(unpublished data). During the national passive surveillance program in 2012, at least two new 64 
reassortants were detected in Danish pigs, one with seven segments derived from H1N1 and a N2 gene 65 
most closely related to that of a human seasonal H3N2 virus that was circulating in the mid 1990-ies 66 
(H1avN2hu) (Breum et al., 2013) and one containing seven segments from H1N1pdm09 and a N2 gene 67 
from H3N2 (H1pdmN2sw) (unpublished data), also detected in German pig populations (Starick et al., 68 
2012).  69 
The increased detection of new reassortants and the lack of knowledge regarding their zoonotic 70 
potential is a worrying aspect and it is therefore of significant importance to genetically and 71 
phenotypically characterize these new reassortants.  72 
In this study, the pathogenicity and transmissibility of two new reassortant SIV’s, the H1avN2hu and 73 
H1pdmN2sw, were compared to H1N2 and H3N2 enzootic European SIV strains in the ferret model. 74 
The ferret model has been widely used for experimental infection with IAVs, due to similarities in 75 
clinical signs and pathogenesis associated with human disease, as well as receptor distribution in the 76 
respiratory tract (Baum & Paulson, 1990; Maher & DeStefano, 2004; van Riel et al., 2007).  77 
RESULTS AND DISCUSSION 78 
Clinical signs and virus shedding  79 
Ferrets were inoculated with 10
6
 TCID50/ml of each virus, a dose previously shown to initiate an 80 
infection (Lednicky et al., 2010; Stark et al., 2013). None of the ferrets developed fever, had nasal 81 
discharges or showed signs of lethargy during the study. The ferrets showed variable weight losses 82 
from mild to moderate (3-10%).  83 
All four viruses replicated in inoculated ferrets and were also found to be transmitted to naïve DC 84 
ferrets (Fig. 1) as assessed by isolation of virus from nasal washes. Infectious virus was detected in 85 
nasal washes until approximately 7 dpi for donor ferrets and 9 dpi for ferrets inoculated with H3N2. 86 
The day of observed peak titers for individual animals infected via direct contact, was found to vary in 87 
the four different groups (Fig. 1). Airborne transmission (AT) was only observed in ferrets inoculated 88 
with H3N2 (Fig. 1). One of the AT ferrets died at 11 dpi although it was concluded that the cause of 89 
death was not related to the infection. Since both AT ferrets in the group inoculated with H3N2 shed 90 
virus and virus was detected in nasal wash from the deceased ferret at 11 dpi, the results of the airborne 91 
transmission were not compromised by its death.  92 
In comparison to the observed DC transmission of the four European SIVs, it has previously been 93 
found that DC transmission in ferrets of a European avian-like H1N1 was poor and no AT was 94 
observed, whereas North American triple reassortant SIV’s were readily transmissible via direct contact 95 
(Barman et al., 2012).  96 
Nasal wash samples from all days post infection were tested by real time RT-PCR to determine if virus 97 
could be replicating at levels too low to be detected by the TCID50 assay. The real time RT-PCR results 98 
was found to support the results obtained from the TCID50 assay. Furthermore, low viral load was 99 
detected in one of the AT ferrets in the H1pdmN2sw group at 3 and 5 dpi, suggesting a potential for 100 
this virus to also become transmissible among ferrets via the airborne route. Taken together, it could 101 
appear that the H1N2/H1avN2hu viruses carrying avian-origin HA, play a less significant role in 102 
transmission compared to the H3N2 and H1pdmN2sw virus carrying human-origin HAs, consistent 103 
with previous results (Barman et al., 2012).  104 
By the end of the experiment IAV antibodies were detected in serum from all inoculated and DC 105 
ferrets, as well as the AT ferret belonging to the H3N2 group (Fig. 2). The ELISA assay was chosen for 106 
antibody detection, due to a too high background response in the HI assay. At 19 and 21 dpi, inoculated 107 
and DC ferrets had all seroconverted.  108 
Viral load in respiratory organs 109 
From each group, two inoculated ferrets were euthanized at 5 dpi for determination of viral titers in 110 
nasal turbinates, trachea, caudal and cranial lung lobe, lymph nodes, intestine, liver and spleen. No viral 111 
replication was detected in liver, spleen, intestines or lymph nodes as was expected, since swine and 112 
human IAV replication is limited to the respiratory tract (Munster et al., 2009; Pascua et al., 2012; 113 
Pearce et al., 2012). 114 
For all viruses, infectious virus particles were recovered from nasal turbinates, trachea and lung lobe 1 115 
and 2 (Fig. 3). Highest viral titers were observed in nasal turbinates with the highest level of virus 116 
particles observed in ferrets inoculated with H1avN2hu and H1N2. In contrast to this result, H1avN2hu 117 
and H1N2 showed lower viral titers in the nasal washes. This could indicate that H1avN2hu replicates 118 
more efficiently in tissues, but that release of new viral particles, is not as efficient and therefore 119 
suggests that the balance between the HA and NA of this virus is not optimal, which could affect viral 120 
transmission.  121 
From the trachea, highest titers were observed in ferrets inoculated with H1avN2hu and H3N2. Viral 122 
replication in caudal and cranial lung lobes 1 and 2 showed the lowest titers, with the highest level of 123 
virus particles observed in ferrets inoculated with H1pdmN2sw and H3N2.  124 
Histopathology 125 
Histopathological examination of the ferrets euthanized at 5 dpi, revealed no significant lesions in 126 
trachea or lung tissue of the control group (Fig. 4a). All four viruses caused hyperemia, edema and 127 
hemorrhage into alveoli as well as varying degrees of non-suppurative interstitial pneumonia, dysplasia 128 
of the bronchiolar epithelium and hyperplasia of the bronchus associated lymphoid tissue (BALT). 129 
Apart from these common characteristics, the severity of the lesions differed among the groups 130 
depending on the virus used for inoculation.  131 
Findings in trachea were alike in the four virus groups, ranging from no lesions to mild dysplasia of the 132 
epithelium, moderate suppurative tracheitis and single cell necrosis.  133 
The viruses H3N2 and H1pdmN2sw caused the most severe lung lesions (Fig. 4b and c) consisting of 134 
suppurative bronchiolitis and bronchitis, as well as epithelial necrosis of serous glands and perivascular 135 
accumulation of mononuclear cells. The inoculated ferrets furthermore had necrosis of bronchiolar 136 
epithelium, and in one of the H3N2 inoculated ferrets mixed bronchopneumonia was seen. The ability 137 
of H3N2 and H1pdmN2sw to induce the most severe lung lesions was consistent with the observed 138 
viral load in the lung lobes for these two viruses.  139 
The H1N2 and H1avN2hu viruses caused infiltration of a few neutrophilic granulocytes and 140 
mononuclear cells in the alveoli (Fig. 4d and e). Both groups of inoculated ferrets (euthanized 5 dpi) 141 
had necrosis of the bronchiolar epithelium. Inoculation with H1avN2hu also induced perivascular 142 
accumulation of mononuclear cells, desquamation of bronchiolar epithelium, suppurative bronchiolitis 143 
and focal epithelial necrosis of serous glands. 144 
In vitro growth kinetics  145 
The in vitro replication capacity of the four European SIV strains was assessed and compared in a 146 
human cell line (NHBE), a swine cell line (pSRECs) and MDCK cells. Cells were inoculated with a 147 
low MOI (0.01).  148 
All four SIVs were able to infect and replicate to high titers in (8.0 - 9.4 log10 TCID50/ml) NHBE cells. 149 
The H1avN2hu and H1pdmN2sw viruses progressively increased in titers until 48 hours post-150 
inoculation (hpi). The H1N2 and H3N2 titers increased until 60 hpi (Fig. 5a). The high level of 151 
replication in NHBE cells of all four SIVs, suggested that these viruses have the ability to infect cells in 152 
the human respiratory airway. 153 
In pSREC an increase in titers was observed until 36 hpi for H1avN2hu and H1N2 and for 154 
H1pdmN2sw and H3N2, an increase in titers was observed until 48hpi and 60 hpi, respectively (Fig. 155 
5b). Mean peak titers in pSRECs were in the range from 6.6 - 7.2 log10 TCID50/ml, where H1N2 was 156 
reaching the highest mean peak titer.  157 
In MDCK cells, the virus titers progressively increased during the first 36 hpi with highest mean peak 158 
titers in the range from 6.3 log10 TCID50/ml to 7.9 log10 TCID50/ml and the highest mean peak titer was 159 
observed for H1N2 (Fig. 5c).  160 
Receptor binding  161 
Binding of the viral HA to host receptors is known to be important for the determination of 162 
transmissibility efficiency and host range restriction (Matrosovich et al., 2004). Hence, glycan binding 163 
properties of the four viruses were investigated by testing for their ability to bind biotinylated 164 
sialylglycopolymers in a dose-dependent fashion.  165 
Previously it has been shown that human IAVs bind preferentially to α2,6-SL and α2,6-SLN and to a 166 
lesser extent α2,3-SL as representatives of α2,6- and α2,3-linked 5-N-Acetylneuraminic acid receptors 167 
(Stevens et al., 2006). In this study, none of the SIVs exhibited strong binding preference towards the 168 
“avian” α2,3-SL and binding to this glycan barely exceeded the threshold. The European SIVs 169 
preferentially bound to the “human/swine” α2,6 sialylglycopolymers, with H3N2 and H1pdmN2sw 170 
showing the highest affinity for the “human/swine” α2,6-SLN. H1avN2hu and H3N2 were found to 171 
also bind α2,6-SL, the short version of the α2,6 sialylglycopolymers. For H1avN2hu and H3N2, it 172 
appeared that as the concentration of sialyglycopolymers were decreased the receptor preference 173 
shifted from the long to the short version of the α2,6 sialylglycopolymer. Results are summarized in 174 
Fig. 6. These findings are consistent with the efficient infection and transmission of the European 175 
H3N2 virus, since it was found to bind both α2,6-SL and α2,6-SLN, but does not explain the less 176 
efficient infection and transmission of the H1avN2hu, that was also shown to bind these two receptor 177 
analogs. 178 
Sequencing 179 
For examination of molecular determinants involved in receptor binding of the European SIVs, full 180 
length HA sequences were obtained from all four viruses using nasal washes from the day of their 181 
highest mean peak viral titers as templates. Amino acids previously shown to be involved in receptor 182 
binding are located at the distal tip of the HA monomer in positions 111 to 265 and is formed by three 183 
secondary structures, termed the 130-loop, the 190-helix and the 220-loop (Gamblin et al., 2004). 184 
The amino acid at residue 190 has been shown to play an important role in binding of SIVs and human 185 
IAVs to the α-2,6 receptor in concert with the amino acid at position 225 (Matrosovich et al., 2000). 186 
For the H1 viruses, 190D was found for H1N2 and H1pdmN2sw, whereas H1avN2hu possessed 190S 187 
(Table 1). It could be speculated that the D to S mutation potentially affects binding of the H1avN2hu 188 
to the α2,6 receptor. 189 
Residue 225 was found to vary between all four European SIVs, where H1avN2hu was found to 190 
possess 225E and H1pdmN2sw showing the “avian” 225D. In H1N2 an E225K mutation was observed 191 
during the study, with the 225E found in inoculum, an inoculated ferret and a DC ferret (Table 1). The 192 
225K variation was found in an inoculated ferret and a DC ferret. The ferrets possessing the E225K 193 
mutation had not been cohoused and thus suggest that this mutation may have been random. The 194 
receptor binding domain at residue 225 has previously been found to be variable in European avian-like 195 
swine strains and has been shown to include the avian 225G, but also 225E and 225K (Dunham et al., 196 
2009).  197 
Investigation of the receptor binding properties of the H3N2 virus showed that the European H3N2 SIV 198 
possessed 155Y and 158G (Table 1), mutations found to be present in human H3’s and both mutations 199 
have previously been shown to play a critical role in recognition of two major molecular species of 200 
sialic acids, namely 5-N-acetylneuraminic acid and 5-N-glycolylneuraminic acid, where 5-N-201 
glycolylneuraminic acid is an analog of sialic acid, expressed in many animal tissues, but absent from 202 
humans (Chou et al., 1998; Matrosovich et al., 2000; Takahashi et al., 2009).  203 
Further, amino acids at residue 226 and 228 have also previously been shown to play a role in receptor 204 
binding (Matrosovich et al., 2000). In H1 HA, “avian” residues 226Q and 228G has been found to be 205 
present in human viruses (Glaser et al., 2005; Matrosovich et al., 2000) and these “avian” residues 206 
were also present in the European avian-like H1 viruses.  207 
The European SIV H3N2 was found to possess 226L and 228S (Table 1). These amino acids have 208 
previously been shown, for the human H3 subtype, to reduce the affinity for α2,3 receptor binding, as 209 
well as increasing the affinity for α2,6 receptors (Matrosovich et al., 2000; Nobusawa et al., 2000; 210 
Rogers et al., 1983). Taken together, these findings are in accordance with the observed ability of 211 
H3N2 to infect both human and swine cell lines, as well as infecting and transmitting between ferrets. 212 
NA kinetics and antiviral susceptibility 213 
Previously it has been suggested that NA activity may facilitate the transmissibility of IAVs (Campbell 214 
et al., 2014) and hence NA enzyme kinetics of the four European SIVs were determined, using the 215 
MUNANA fluorogenic substrate. The Michaelis-Menten constant (KM) is an estimate of the 216 
dissociation equilibrium for substrate binding to enzyme and thereby reflects the enzyme affinity for 217 
the substrate, where Vmax reflects the enzyme’s catalytic activity. All four European SIVs showed high 218 
Km values, ranging from 281 µM for H3N2 to 492 µM for H1N2, compared to N1 viruses (Hooper & 219 
Bloom, 2013; Ilyushina et al., 2010; Yen et al., 2011). Vmax values were found to be in the range from 220 
842 U/sec for H3N2 to 1845 U/sec for H1pdmN2sw (Table 2). 221 
It has previously been found that PR8 modified by reverse genetics to contain a pandemic matrix (M) 222 
gene, enhanced NA activity (Campbell et al., 2014). Of the European SIVs, only H1pdmN2sw 223 
contained a pandemic M gene and interestingly, the H1pdmN2sw showed higher enzyme activity (a 224 
higher Vmax) than the H3N2 virus, despite comparable KM values. These findings suggest that high NA 225 
activity alone cannot be responsible for the airborne transmission observed for the H3N2 virus. It 226 
would be interesting though, to test if NA activity and transmission efficiency of the European H3N2 227 
virus would increase further if the original M gene was replaced with a pandemic M gene.  228 
Previously it has been shown that H1N1pdm09 was transmissible among ferrets by the airbourne route, 229 
in spite of a much lower NA activity (Yen et al., 2011), compared to the one observed for 230 
H1pdmN2sw.  In the same study, it was suggested that an optimal HA-NA balance is required for 231 
airborne transmission, and it could therefore be speculated that this balance is not optimal in the 232 
H1pdmN2sw virus. 233 
The antiviral susceptibility of the four European SIVs to three of the most commonly used 234 
neuraminidase inhibitors (Oseltamivir carboxylase, Zanamivir and Peramivir) was also tested and all of 235 
the European SIVs were found to be sensitive to all of the neuraminidase inhibitors tested (Table 2).  236 
Here we have shown that four European SIVs, including two new reassortants and two enzootic 237 
viruses, transmitted efficiently in the ferret model via direct contact. Furthermore, we showed that one 238 
of these viruses, H3N2, was the only virus able to transmit via the airborne route. These results, 239 
combined with the efficient transmission of this virus to DC ferrets and the high viral titers in both 240 
nasal turbinates and trachea, showed altogether that this virus was the most effective, of the four 241 
European SIVs, for replication and transmission in the ferret model. Furthermore, the ability of this 242 
virus to replicate in human respiratory cells suggests that this virus could potentially transmit to 243 
humans. For the past 25 years, the European H3N2 virus has been adapting to swine and the degree of 244 
antigenic divergence between this virus and the human seasonal H3N2 virus is likely to have increased 245 
dramatically. A recent study did show that contemporary human seasonal H3N2 viruses had obtained 246 
substantial antigenic distance from swine H3N2 viruses, even though the lineages shared a common 247 
ancestor. Hence, the authors speculated that this increasing distance could pose a risk for the youngest 248 
of the human population, since they could become increasingly susceptible to infections with swine 249 
H3N2 due to the lack of cross-reacting immunity (Lewis et al., 2014). These findings stress the need 250 
for a continued and systematic surveillance of the European SIVs in order to detect new reassortants as 251 
well as monitoring the evolution and zoonotic potential of both reassortant and enzootic SIV strains. 252 
METHODS 253 
Viruses 254 
A/swine/Denmark/10302-2/2012(H1N2), A/swine/Denmark/10845-1/2012(H1N2), 255 
A/swine/Denmark/101394-1/2011(H1N2) and A/swine/Denmark/101501-1/2010(H3N2) (hereafter 256 
referred to as H1avN2hu, H1pdmN2sw, H1N2 and H3N2, respectively) were isolated from lung 257 
samples submitted for diagnostic purposes from swine with a history of respiratory disease. Viruses 258 
were grown and titrated in Madin-Darby canine kidney (MDCK) cells. Before inoculation, influenza 259 
viruses were passaged in the allantoic cavity of 10-day-old embryonated chicken eggs (Marshall 260 
Durbin, Birmingham, AL) at 35°C for 72 h. All isolates underwent a maximum of two passages in eggs 261 
and/or cells. 262 
Cell cultures 263 
MDCK cells were grown in Minimum Essential Medium Eagle (MEM) (Gibco, Carlsbad, CA, USA) 264 
containing 5% fetal calf serum (FCS), 2 mM L-glutamine, Non-essential amino acids (NEAA) and 265 
penicillin-streptomycin. Normal human bronchial epithelial cells (NHBE) in individual inserts were 266 
obtained from MatTek Corporation (Ashland, MA, USA). The cells were grown in AIR-100-ASY 267 
(MatTek Corporation Ashland, MA, USA) serum free media containing growth factors. The apical 268 
surface was washed to remove mucus and media was changed every other day.  269 
Primary swine respiratory epithelial cells (pSREC) were seeded into type VI collagen (Sigma-Aldrich, 270 
St. Louis, MO, USA)-coated tissue culture flasks and grown in Bronchial Epithelial Cell Growth 271 
medium (BEGM, Lonza, Walkersville, MD, USA) with SingleQuots™ Kit containing growth factors, 272 
and cytokines. Medium was further supplemented with 5% FCS and 1% 273 
penicillin/streptomycin/amphotericin (Sigma, St. Louis, MO, US) and passaged up to five times prior to 274 
infection. All cells were grown at 37°C in a 5% CO2 atmosphere. 275 
Infection and replication kinetics 276 
For preparation of viral stocks, lung tissue was homogenized on TissueLyser (Qiagen, GmbH, 277 
Germany) in 1.5 mL MEM supplemented with penicillin-streptomycin and sterile filtered. MDCK cells 278 
were inoculated with 500 µL lung tissue homogenate for 30 min at 37°C, 5% CO2. Following 279 
incubation, 10 mL MEM containing penicillin-streptomycin, NEAA, 2 mM L-glutamine and 2 µg/mL 280 
tosylsulfonyl-phenylalanyl-chloromethyl-ketone (TPCK)-treated trypsin (Sigma-Aldrich, St. Louis, 281 
MO, USA) was added to the cells. The cells were incubated for 72 h and daily monitored for cytopathic 282 
effects (CPE). The supernatant was harvested and centrifuged at 2500 rpm for 30 minutes to clarify cell 283 
debris and then stored at -80°C until further use.  284 
TCID50 and pfu were determined by incubating serial dilutions of virus in MDCK cells at 37°C for 72 285 
h. A hemagglutination assay was performed to determine the end point of infection and TCID50 was 286 
calculated using the method of Reed and Muench (Reed & Muench, 1938).  287 
Replication kinetics in MDCK cells were determined at a MOI of 0.01 pfu per cell. After 1 h of 288 
incubation the MDCK cells were washed and overlaid with infection medium (MEM containing 2% 289 
BSA, pen-strep, amino acids and TPCK-treated trypsin). Supernatants were collected and stored at -290 
80°C for virus titration. Replication kinetics in differentiated NHBE cells were determined at a MOI of 291 
0.01 pfu per cell. Cells were washed with PBS and were inoculated via the apical side with 200 µl 292 
diluted virus in the absence of trypsin. After 1 h of incubation at 37°C, viral inoculum was removed 293 
and cells were washed. Cells were then pre-incubated with 200 µl fresh medium at 37°C for 30 min 294 
prior to sample collection at specified time points. Samples were stored at -80°C. Replication kinetics 295 
in pSRECs was determined at an MOI of 0.01 pfu per cell. Cells were washed and infection medium 296 
(BEGM, Lonza, Walkersville, MD, USA) containing 0.5% BSA was added, supernatants were 297 
collected at specified time points and stored at -80°C for virus titration.  298 
RNA purification and real time RT-PCR screening 299 
Viral RNA was purified from cultured viruses by RNeasy Mini Kit (Qiagen, GmbH, Germany) 300 
according to manufacturer’s instructions. Cell culture supernatant was prepared by mixing 200 µl 301 
sample with 400 µl RLT-buffer containing –mercaptoethanol. Total RNA was eluted in 60 µl RNase-302 
free water and stored at -80C. 303 
The presence of influenza A virus was confirmed by real-time RT-PCR using an in-house modified 304 
assay for detection of the matrix gene (De Vleeschauwer et al., 2009).  305 
Full genome sequencing and RT-PCR 306 
Nucleic acid amplification was performed by one-step RT-PCR using primers modified from 307 
Hoffmann et al., (Hoffmann et al., 2001) and the Superscript III One-Step RT-PCR kit with Platinum 308 
Taq High Fidelity (Invitrogen, Carlsbad, CA, USA). PCR cycling conditions for HA was as follows: 30 309 
min at 55°C, 2 min at 94°C, four cycles of 94°C for 30 sec, 55°C for 30 sec, 68°C for 180 sec, followed 310 
by 40 cycles of 94°C for 30 sec and 68°C for 210 sec and then 68°C for 10 min. For NA the same 311 
conditions were used, except that reverse transcriptase temperature was 54°C and annealing 312 
temperature 58°C. 313 
The PCR products were visualized by gel electrophoresis using E-Gel 0.8% agarose gels (Invitrogen, 314 
Carlsbad, CA, USA) and purified with High Pure PCR Product Purification Kit (Roche Diagnostics, 315 
GmbH, Germany). Purified PCR products were sent for single sample sequencing at LGC Genomics 316 
(GmbH, Germany). 317 
Full genome sequencing was performed on two cell culture propagated influenza positive samples by 318 
full length amplification of all 8 gene segments with in-house designed primers (primers available upon 319 
request) using SuperScript III OneStep RT-PCR System with Platinum Taq High Fidelity and PCR 320 
conditions similar to that described for HA full length amplification. Purified PCR products for all gene 321 
segments were pooled in equimolar quantity to a final amount of 1 µg and used for next generation 322 
sequencing (NGS) on the Ion Torrent PGM™ sequencer (Life Technologies, Carlsbad, CA, USA). 323 
NGS including library preparation was carried out at the Multi-Assay Core facility located at the 324 
Technical University of Denmark.   325 
Sequence analysis 326 
Sequences obtained by NGS were assembled using the de novo and reference assembly tools of CLC 327 
Genomics Workbench 4.6.1 (CLC bio A/S, Århus, Denmark). Sequences obtained by Sanger 328 
sequencing was analyzed using CLC Main Workbench Version 6.9 (CLC bio A/S). 329 
Animals 330 
All animal experiments were performed in Animal Biosafety Level 2 facilities at St. Jude Children 331 
Research Hospital (Memphis, TN, USA), in compliance with the policies of the National Institutes of 332 
Health and the Animal Welfare Act and with the approval of the St. Jude Children’s Research Hospital 333 
Animal Care and Use Committee. In total, 36 four to six month old ferrets (Triple F farms, Sayre, PA, 334 
US), weighing 0.8-1.6 kg, that had been tested negative to current circulating human influenza subtypes 335 
by hemagglutination inhibition (HI) assay were used.  336 
Transmission and pathogenicity studies 337 
Before inoculation of the donor ferrets, baseline body temperatures and weights were documented for 338 
all ferrets. Donor and contact ferrets were housed separately. Four donor ferrets from each group were 339 
anesthetized with isoflurane and inoculated intranasally with 10
6
 TCID50 influenza virus in 1 ml PBS 340 
with antibiotics and antimycotic (Sigma, St. Louis, MO; 100 U/ml penicillin, 100 mg streptomycin, and 341 
0.25 mg amphomycin per ml) with 500 µl in each nostril. Transmission experiments (1 donor+1 direct-342 
contact (DC) recipient+1 airborne-transmission (AT) recipient) were conducted in duplicate for each 343 
virus. At day 1 post infection (dpi) each donor was co-housed with one naive DC ferret. One additional 344 
naive ferret was placed in an adjacent cage separated by double-layered perforated dividers that 345 
prevented physical contact but allowed the passage of respiratory droplets, to assess for AT.  346 
After inoculation, temperature, weight and clinical signs were recorded every other day for 11 days. 347 
Nasal washes 348 
Nasal washes were collected at 1 dpi for donor ferrets and at 3, 5, 7, 9 and 11 dpi for all ferrets. Ferrets 349 
were anesthetized intramuscularly with 20-50 mg/kg of Ketamine, nostrils were flushed with 1 ml of 350 
PBS containing antibiotics and antimycotic (Sigma, St. Louis, MO, USA; 100 U/ml penicillin, 100 mg 351 
streptomycin, and 0.25 mg amphomycin per ml) with 500 µl in each nostril and collected into cups. 352 
Nasal washes were spun down and stored at -80°C until further analysis. TCID50 were determined in 353 
MDCK cells and expressed as TCID50/ml. 354 
Ferret organ collection and virus titration 355 
At 5 dpi two inoculated ferrets from each group were sacrificed for pathological examination. The 356 
remaining ferrets were sacrificed at 21 dpi and the following tissues were collected from all animals; 357 
nasal turbinates, trachea, Right/left caudal and cranial lung lobes, lymph nodes, intestine, liver and 358 
spleen. Tissues were weighed and homogenized in MEM with antibiotics. Virus titers were determined 359 
in MDCK cells as described above and expressed as TCID50/g tissue. 360 
Serological tests 361 
Serum samples collected at 0 and 1 dpi and at 19 and 21 dpi were tested for antibodies. The serum 362 
samples were tested in a blocking ELISA using the commercially available influenza A antibody test 363 
kit, detecting antibodies against the NP gene (IDEXX Laboratories A/S, Switzerland), according to 364 
manufacturer’s instructions. The ELISA antibody values were calculated as optical density (OD) from 365 
each sample and presented as percent transmittance. 366 
Histopathology 367 
Samples of trachea and the left/right cranial and dorsal lung lobes were collected from two control 368 
ferrets and all inoculated ferrets at 5 dpi, and the remaining ferrets at 21 dpi. The tissues were fixed in 369 
10% neutral buffered formalin, embedded in paraffin and slides were processed by routine methods for 370 
histology, stained with hematoxylin and eosin and examined in a blinded fashion.  371 
Receptor assay 372 
The four viruses were tested for their HA binding activity to the following glycans; α2,3-SL 373 
(Neu5Acα2-3Galβ1-4Glcβ-PAA-Biotin), α2,6-SL (Neu5Acα2-6Galβ1-4Glcβ-PAA-Biotin) and α2,6-374 
SLN (Neu5Acα2-6Galβ1-4GlcNAcβ-PAA-Biotin) (Glycotech Corp., Gaithersburg, MD, US) as 375 
previously described (Matrosovich & Gambaryan, 2012).   376 
NA kinetics and antiviral susceptibility to neuraminidase inhibitors 377 
NA kinetics and antiviral susceptibility to NA inhibitors (NAI) were based on the method of Potier et 378 
al. (Potier et al., 1979) using methylumbelliferone N-acetylneuraminic acid (MUNANA; Sigma-379 
Aldrich, St Louis, MO) substrate, as described by (Jones et al., 2014).  380 
Enzyme kinetics data were fitted by non-linear regression to the Michaelis-Menten equation using 381 
GraphPad Prism version 5 (GraphPad Software, La Jolla, CA, USA) to determine the Michaelis 382 
Menten constant and maximum velocity (Vmax) of substrate conversion. 383 
Sensitivity of NA to oseltamivir carboxylate (oseltamivir) from Hoffmann-La Roche (Basel, 384 
Switzerland), zanamivir from Glaxo-SmithKline (Research Triangle Park, NC, USA), and peramivir 385 
from BioCryst Pharmaceuticals (Birmingham, AL, USA) was tested by using dilutions of inhibitors 386 
ranging from 5×10
-7
 µM to 50 µM. The drug concentration that inhibited 50% of the NA enzymatic 387 
activity (IC50) was determined from the dose-response curve with GraphPad Software version 5. 388 
Results are expressed as the average of two independent tests. 389 
Statistical analysis 390 
Two-way ANOVA with Bonferoni’s posttest was performed using GraphPad Prism version 5. 391 
Nucleotide sequence accession numbers 392 
The GenBank accession numbers of HA for A/swine/Denmark/10845-1/2012(H1N2), 393 
A/swine/Denmark/101394-1/2011(H1N2) and A/swine/Denmark/101501-1/2010(H3N2) are 394 
KP202355, KP202356 and KP202357, respectively. 395 
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 524 
Fig. 1. Replication kinetics in the upper respiratory tract. Groups of four ferrets were intranasally 525 
inoculated with 1 ml of 10
6
 TCID50 (0.5 ml per nostril) of the respective viruses. Each virus group 526 
contained eight ferrets, four donor ferrets (until 5 dpi), two direct contacts and two airborne 527 
transmission contacts. (a) H1avN2hu (b) H1N2 (c) H3N2 (d) H1pdmN2sw. Nasal washes were 528 
collected on days 1, 3, 5, 7, 9 and 11 after infection. Data are presented as mean virus titer ± SEM 529 
(log10 TCID50/ml) on the indicated day. Limit of detection was 10
1
 TCID50/ml. 530 
 531 
Fig. 2. Seroconversion of ferrets. Ferrets were tested for seroconversion at 19 and 21 dpi, using a 532 
blocking-ELISA, detecting antibodies against the NP gene. In the H3N2 AT group one of the animals 533 
died before seroconversion and hence only one animal is above the baseline. Serum samples were 534 
tested in duplicate and mean values are presented as percent seropositive ± SEM. 535 
 536 
Fig. 3. Comparison of European swine influenza virus titers recovered from ferret tissues. Ferrets 537 
were inoculated intranasally with 1 ml of 10
6
 TCID50 (0.5 ml per nostril) with H1N2, H1avN2hu, 538 
H3N2 or H1pdmN2sw, and tissues were collected at day 5 p.i. Titers are expressed as log10 TCID50 per 539 
gram of tissue. Each bar represents two ferrets. Data are presented as mean virus titer ± SEM (log10 540 
TCID50/g) from the indicated tissue. Limit of detection was 10
1
 TCID50/g. 541 
 542 
Fig. 4. Lung pathology in ferrets inoculated with one of the four European swine influenza 543 
viruses and euthanized 5 days post infection a-e) Lung tissue from ferrets, hematoxylin and eosin, 544 
scale bar 50 µm. a) Normal lung tissue from control ferret; b) Ferret inoculated with H3N2, 5 days post 545 
infection (dpi). Suppurative bronchiolitis, dysplasia of bronchiolar epithelium and hyperplasia of the 546 
bronchus associated lymphoid tissue (BALT) (asterisks); c) Ferret inoculated with H1pdmN2sw, 5 dpi. 547 
Suppurative bronchiolitis, dysplasia and desquamation (arrowhead) of bronchiolar epithelium and 548 
BALT hyperplasia (asterisks); d) Ferret inoculated with H1N2, 5 dpi. Suppurative bronchiolitis and 549 
peribronchiolar infiltration of mononuclear cells. Dysplasia, necrosis and desquamation (arrowhead) of 550 
bronchiolar epithelium; e) Ferret inoculated with H1avN2hu, 5 dpi. Suppurative bronchiolitis, and 551 
dysplasia, necrosis and desquamation (arrowhead) of bronchiolar epithelium.  552 
 553 
Fig. 5. Replication kinetics of European swine influenza viruses in different cell lines. Growth 554 
curves were obtained by inoculating cells with an MOI of 0.01 PFU/cell with H1N2, H1avN2hu, 555 
H1pdmN2sw or H3N2, respectively. Supernatant was harvested and titrated in MDCK cells at 8, 10, 556 
12, 18, 20, 24, 36, 48 and 60 hours post infection. Data are expressed as mean log10 TCID50 ± SEM 557 
from two independent experiments titered in quadruplicate.  558 
 559 
Fig. 6. Receptor specificity of four European swine influenza viruses. The receptor-binding 560 
specificity of the four European swine influenza viruses H1N2, H1avN2hu, H1pdmN2sw and H3N2 561 
were tested in a dose dependent glycan array assay against the sialyl glycans α2,6-SL and α2,6-SLN 562 
and  α2,3SL.  563 
 564 
 565 
 566 
 567 
 568 
 569 
 570 
 571 
 572 
 573 
Table 1. Sequencing data from important residues in the four swine influenza viruses. 574 
Residue Virus 
 H1avN2hu H1pdmN2sw H1N2 H3N2 
155 - - - Y 
158 - - - G 
190 S D D - 
225 E D E/K - 
226 Q Q Q L 
228 G G G S 
   
25 
 
 575 
TABLE 2. NA enzyme kinetics and antiviral susceptibility of European swine influenza viruses using 576 
MUNANA substrate 577 
 
 
Virus 
Vmax  
[mean (95% CI)] 
Km (µM)  
[mean (95% CI)] 
 
        IC50 (nM) [mean (95% CI)] 
 
Oseltamivir Zanamivir Peramivir 
H1avN2hu 1364  
(1257-1472) 
376.5  
(272.6-480.4) 
0.10  
(0.07-0.14) 
0.43 
(0.25-0.75) 
0.14  
(0.08-0.26) 
H1pdmN2sw 1845  
(1655-2036) 
487  
(320.5-653.6) 
0.29  
(0.19-0.44) 
1.59  
(0.85-2.98) 
0.48  
(0.30-0.77) 
H1N2 1495  
(1219-1772) 
492  
(191.7-792.4) 
0.47  
(0.31-0.72) 
1.48  
(0.86-2.56) 
0.66  
(0.43-1.01) 
H3N2 842.4  
(743.9-940.9) 
281.1  
(158.7-403.5) 
0.08  
(0.05-0.12) 
0.14  
(0.05-0.35) 
0.10  
(0.07-0.14) 
The Michaelis-Menten constant (Km) and maximum velocity (Vmax) of substrate conversion were 578 
fitted to the Michaelis-Menten kinetics by non-linear regression. CI, confidence interval. 579 
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